Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

OncoMed Pharmaceuticals Inc Products   
800 Chesapeake Dr
Redwood City,  CA  94063
United States
Telephone: (650) 995-8200
Fax: (650) 298-8600
URL: http://www.oncomed.com
Email: info@oncomed.com

OncoMed Pharmaceuticals Incorporated, founded in 2004 and based in Redwood City, California, has developed processes that support the identification and monitoring of tumor-initiating 'cancer stem cells.' The company uses tumor models created with human primary tumor xenografts. The proprietary models are developed with intellectual property licensed exclusively to OncoMed Pharmaceuticals. The company has tested over 150 antibodies in xenograft models. OncoMed Pharmaceuticals has assembled a portfolio of active antibodies that target tumor-initiating biologic pathways. The firm has produced panels of monoclonal antibodies against key signaling molecules expressed in tumor-initiating cells. The company has employed limiting dilution assays to measure the effectiveness of antibodies. OncoMed Pharmaceuticals uses in vitro and in vivo assays. The company has formed a strategic alliance with GlaxoSmithKline. Investors include US Venture Partners, Latterell Venture Partners, Morgenthaler Ventures, The Vertical Group, Adams Street Partners, De Novo Ventures, and Bay Partners. OncoMed Pharmaceuticals was founded by Dr. Michael F. Clark and Dr. Max Wicha.

Org. Type: Corporation Equity Type: Private
Company Status: Active Date Founded: 2004

Products:
OncoMed Pharmaceuticals Inc--Company News

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.